p53 gene mutations in soft-tissue sarcomas - Correlations with p53 immunohistochemistry and DNA ploidy

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 4, 1997, Pages 211-218

  Schneider Stock, Regine ^a   Radig, Kathrin ^a   Oda, Yoshinao ^b   Mellin, Walter ^a   Rys, Janusz ^c   Niezabitowski, Aleksander ^c   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b KYUSHU UNIVERSITY   (Japan)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

DNA ploidy; p53 gene mutation; p53 immunohistochemistry; PCR SSCP analysis; soft tissue tumors

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PLOIDIES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030994960     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050049     Document Type: Article

References (41)

1. Andreassen A, Oyjord T, Hovig E, Holm R, Florenes VA, Nesland JM, Myklebost O, Hoie J, Bruland OS, Borresen AL, Fodstad O (1993) p53 abnormalities in different subtypes of human sarcomas Cancer Res 53: 468-471
2. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR (1991) p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res 51: 6393-6396
3. Bueso-Ramos CE, Yang Y, Manshouri T, Feltz L, Ayala A, Glassman AB, Albitar M (1995) Molecular abnormalities of the MDM-2 in human sarcomas. Int J Oncol 7: 1043-1048
4. Castresana JS, Barrios C, Gomez L, Kreicbergs A (1994) No association between c-myc amplification and TP53 mutation in sarcoma tumorigenesis. Cancer Genet Cytogenet 76: 47-49
5. Chang F, Syrjänen S, Syrjänen K (1995) Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 13: 1009-1022
6. Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1992) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
7. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799
8. Dobashi Y, Sugimura H, Sato A, Hirabayashi T, Kanda H, Kitagawa T, Kawaguchi N, Imamura T, Machinami R (1993) Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Diagn Mol Pathol 2: 257-263
9. Dockhorn-Dworniczak B Schäfer KL, Dantcheva R, Blasius S, Winkelmann W, Strehl S, Burdach S, Valen F van, Jürgens H, Böcker W (1994) Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms. Virchows Arch 424: 337-342
10. Donghi R, Longoni A, Pilotti S, Michieli P, Della-Porta G, Pierotti MA (1993) Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91: 1753-1760
11. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon-Cardo C (1994) Prognostic implication of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 86: 549-554
12. Dutta A, Ruppert JM, Aster JC, Winchester E (1993) Inhibition of DNA replication factor RPA by p53. Nature 365: 79-82
13. Enzinger FM, Weiss SW (1995) Soft tissue tumors, 3rd edn. Mosby, St. Louis, Baltimore
14. Goldmann D, Merril CR (1982) Silver staining of DNA in polyacrylamide gels: linearity and effect of fragment size. Electrophoresis 3: 24-26
15. Hall AP, Lane PD (1994) p53 in tumor pathology: can we trust immunohistochemistry? Revisited! J Pathol 172: 1-4
16. Hamelin R, Jego N, Laurent-Puig P, Vidaud M, Thomas G (1993). Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene 8: 2213-2220
17. Hayashi K (1991) PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Applications 1: 34-38
18. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H (1994) Nuclear immunoreaction of p53 protein in soft tissue sarcomas. Cancer 73: 2499-2505
19. Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M, Gadner H (1993) Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene 8: 2683-2690
20. Lane DP (1992) P53, guardian of the genome. Nature 358: 15-16
21. Latres E, Drobnjak M, Pollack D, Oliva MR, Ramos M, Karpeh M, Woodruff JM, Cordon-Cardo C (1994) Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. Am J Pathol 145: 345-355
22. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D (1993) The 1993 Walter Hubert Lecture. The role of the p53 tumor suppressor gene in tumorigenesis. Br J Cancer 69: 409-416
23. Liu F, Ho ES, Chen JT, Shih RT, Yang C, Shih A (1994) Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumors. Cancer 76: 291-295
24. Lustbader ED, Williams WR, Bondy ML, Strom S, Strong LC (1992) Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet 51: 344-356
25. Mellin W, Niezabitowski A, Brockmann M, Ritter J, Wuisman P, Krieg V (1995) DNA ploidy in soft tissue tumors: an evaluation of the prognostic implications in the different tumor types. Curr Top Pathol 89: 95-121
26. Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B, Koeffler HP (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50: 7950-7954
27. Mousses S, Mcauley L, Bell RS, Kandel R, Andrulis IL (1996) Molecular and immunohistochemical identification of p53 alterations in hone and soft tissue sarcomas. Mod Pathol 9: 1-6
28. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83
29. Orita M, Suzuki Y, Sekyia T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879
30. Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CDM, Thomas M, Grimer R, Gusterson BA, Cooper CS (1994) Abnormalities of the p53, MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer 69: 1052-1058
31. Reid AH, Tsai MM, Venzon DJ, Wright CF, Lack EE, O'Leary TJ (1996) MDM2 amplification, p53 mutation, and accumulation of the p53 gene product in malignant fibrous histiocytoma. Diagn Mol Pathol 5: 65-73
32. Sachs L (1992) Angewandte Statistik, 7th edn. Springer, Heidelberg
33. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
34. Schneider-Stock R, Oda Y, Roessner A (1997) A new splicing mutation in exon 5-6 of the p53-tumor suppressor gene in a malignant schwannoma. Hum Mutat 9:91-97
35. Simms WW, Ordonez NG, Johnston D, Ayala AG, Czerniak B (1995) P53 expression in dedifferentiated chondrosarcoma. Cancer 76: 223-227
36. Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher CDM, Ball A, Thomas M, Gusterson BA, Cooper CS (1990) Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 5: 1297-1301
37. Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H, Rath FW (1995) Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma. Cancer 76: 1187-1196
38. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52: 6194-6199
39. Vojtesek B, Bartek J, Midgley CA, Lane DP (1992) An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237-244
40. Vogelstein B, Kinzler KW (1992) P53 function and dysfunction. Cell 70: 523-526
41. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y, Yamamuro T (1993) P53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68: 1134-1139